🟢 Achieve Life Sciences is trading 6% up in pre-market with no confirmed company-specific catalyst

Achieve Life Sciences is trading at $7.99, up 6.11% in pre-market, with no confirmed company-specific catalyst.

• Broader U.S. indices were higher pre-market, providing a positive backdrop, while biotech sector context was negative.
• Achieve Life Sciences announced Benjamin Halladay’s CFO appointment on October 1, effective October 5; available reporting does not establish it as the reason for the rise.
• The prior close was $7.53 on October 1; no volume or activity data was provided.